Deutsche Märkte geschlossen

Amgen Inc. (AMGN)

NasdaqGS - NasdaqGS Echtzeitpreis. Währung in USD
Zur Watchlist hinzufügen
225,40-3,01 (-1,32%)
Börsenschluss: 04:00PM EDT
225,50 +0,10 (+0,04%)
Nachbörse: 07:32PM EDT

Amgen Inc.

One Amgen Center Drive
Thousand Oaks, CA 91320-1799
United States
805 447 1000
https://www.amgen.com

Sektor(en)Healthcare
BrancheDrug Manufacturers—General
Vollzeitmitarbeiter24.200

Leitende Angestellte

NameTitelZahlenAusgeübtGeburtsjahr
Mr. Robert A. BradwayChairman, CEO & Pres5,81M13,3M1963
Mr. Peter H. GriffithExec. VP & CFO2,66MN/A1959
Mr. Esteban SantosExec. VP of Operations2,61MN/A1968
Dr. David M. Reese M.D.Exec. VP of R&D2,79M419,8k1963
Mr. Murdo GordonExec. VP of Global Commercial Operations2,82MN/A1967
Ms. Linda H. LouieVP of Fin. & Chief Accounting OfficerN/AN/AN/A
Mr. Mike ZahigianSr. VP & Chief Information OfficerN/AN/AN/A
Mr. Arvind SoodVP of Investor RelationsN/AN/AN/A
Mr. Jonathan P. GrahamExec. VP, Gen. Counsel & Sec.N/AN/A1961
Ms. Nancy A. GrygielSr. VP of Worldwide Compliance & Bus. Ethics and Chief Compliance OfficerN/AN/A1968
Die Beträge haben den Stand 31. Dezember 2021 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in USD.

Beschreibung

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces the chance of infection due a low white blood cell count in patients cancer; Prolia to treat postmenopausal women with osteoporosis; Xgeva for skeletal-related events prevention; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Aranesp to treat a lower-than-normal number of red blood cells and anemia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; and Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization. It also markets Nplate, Vectibix, MVASI, Parsabiv, EPOGEN, KANJINTI, BLINCYTO, Aimovig, EVENITY, AMGEVITATM, Sensipar/Mimpara, NEUPOGEN, IMLYGIC, Corlanor, and AVSOLA. Amgen Inc. serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. It has collaboration agreements with Novartis Pharma AG; UCB; Bayer HealthCare LLC; BeiGene, Ltd.; Eli Lilly and Company; Datos Health; and Verastem, Inc. to evaluate VS-6766 in combination with lumakrastm (Sotorasib) in patients with KRAS G12C-mutant non-small cell lung cancer. It has an agreement with Kyowa Kirin Co., Ltd. to jointly develop and commercialize KHK4083, a Phase 3-ready anti-OX40 fully human monoclonal antibody for the treatment of atopic dermatitis and other autoimmune diseases; and research and development collaboration with Neumora Therapeutics, Inc. and Plexium, Inc. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California.

Corporate Governance

Amgen Inc.s ISS Governance QualityScore, Stand 28. September 2022, lautet 2. Die grundlegenden Scores sind Audit: 6, Vorstand: 9, Shareholderrechte: 1, Kompensation: 1.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.